Join to View Full Profile
Rockefeller Neurosciences InstituteRockville, MD 20850
Phone+1 301-294-7188
Dr. Alkon is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Weill Cornell MedicineClass of 1969
Certifications & Licensure
MD State Medical License 1973 - 2018
WV State Medical License 2013 - 2018
Publications & Presentations
PubMed
- 7 citationsChronic bryostatin-1 rescues autistic and cognitive phenotypes in the fragile X mice.Patricia Cogram, Daniel L. Alkon, David Crockford, Robert M. J. Deacon, Michael J. Hurley
Scientific Reports. 2020-10-22 - 19 citationsNeuro-regeneration Therapeutic for Alzheimer's Dementia: Perspectives on Neurotrophic Activity.Miao-Kun Sun, Daniel L. Alkon
Trends in Pharmacological Sciences. 2019-09-01 - 48 citationsA Randomized, Double-Blind, Placebo-Controlled, Phase II Study Assessing Safety, Tolerability, and Efficacy of Bryostatin in the Treatment of Moderately Severe to Seve...Martin R. Farlow, Richard E. Thompson, Lee-Jen Wei, Alan J. Tuchman, Elaine Grenier
Journal of Alzheimer's Disease. 2019-01-01
Press Mentions
SYNAPS Dx Documents Need for Highly Accurate, Accessible and Non-Invasive Alzheimer’s Disease Diagnostic as Alternative to Blood-Based BiomarkersApril 4th, 2023- Synaptogenix Provides Corporate Update and Outlines Potential Business OpportunitiesMarch 7th, 2023
- Early, Accurate Diagnosis of Alzheimer’s Disease with DISCERN™ Test Is Critical for Identifying Appropriate Patients for Prescribing and Coverage of LEQEMBI™January 10th, 2023
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
